Feature Channels:

Cardiovascular Health

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Clinical Practice Guideline , Anticoagulants, Anticoagulation, Cardiothoracic Surgery, The Annals of Thoracic Surgery, blood thinning medication, Cardiopulmonary Bypass, Heparin, Protamine

New Clinical Practice Guideline Addresses Use of Blood Thinners During Heart Surgery

Linda-Shore-Lesserson.png

The Society of Thoracic Surgeons (STS), the Society of Cardiovascular Anesthesiologists (SCA), and the American Society of ExtraCorporeal Technology (AmSECT) released a new clinical practice guideline that includes major recommendations for the use of blood thinning medication (anticoagulants) during heart surgery.

Medicine

Science

Channels:

Neurogastronomy, After Surgical Weight Loss, Probiotic Akkermansia and More in the Obesity News Source

Click here to go directly to Newswise's Obesity News Source

Medicine

Channels:

Heart Health, Diabetes, Cardiovascular Disease, American Heart Month, heart healthy lifestyle, Prediabetes

CRF Invites the NYC Community to Attend Free Seminar on the Link Between Diabetes and Heart Disease During American Heart Month

CRFWHHIMini-MedSchoolFebruarySeminar-1.jpg

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” on Wednesday, February 7, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing attendees a deeper understanding of diabetes and its connection with cardiovascular disease.

Medicine

Channels:

Case Western Reserve University School Of Medicine, University Hospitals Cleveland Medical Center, Jonathan Stamler, Enzymes, Cell Function, Nitric Oxide, NO, SNOs, Heart Failure, Cancer, Asthma, Infection, NO synthases, S-nitrosylation, Therapeutic Targets, drug developers, Memory, Molecular Cell

Researchers Discover New Enzymes Central to Cell Function

Doctors have long treated heart attacks, improved asthma symptoms, and cured impotence by increasing levels of a single molecule in the body: nitric oxide. The tiny molecule can change how proteins function. But new research featured in Molecular Cell suggests supplementing nitric oxide—NO—is only the first step. Researchers have discovered previously unknown enzymes in the body that convert NO into “stopgap” molecules—SNOs—that then modulate proteins. The newly discovered enzymes help NO have diverse roles in cells. They may also be prime therapeutic targets to treat a range of diseases.

Medicine

Channels:

Caregiving, Chronic Illness, Health Support, Diabetes, Heart Disease, Arthritis, Lung Disease, Depression

In Chronic Disease Care, Family Helpers Are Key, But Feel Left Out

michigan-med-l-chronic-care-01.jpg

People with diabetes, heart failure and other chronic diseases often live independent lives, without a traditional caregiver. But many have a family member or friend who plays a key supporting role in their health care.

Medicine

Channels:

Heart Attack, Cardiac Arrest, Troponin, Blood Test

New Blood Test for Diagnosing Heart Attacks: A ‘Big Deal,’ with Caveats

michigan-med-l-ed-heart-01.jpg

A longtime blood test that measures the likelihood of a cardiac event has become more sensitive and more precise. Why doctors and patients should be cautiously optimistic.

Medicine

Channels:

High Cholesterol, cholesterol management, Penn Medicine, perelman school of medicine , Health Insurance, Prescription Drug Benefit, Cardiology, Cardiovascular Medicine, PCSK9 Inhibitors, Cardiovascular Quality

Insurance Company Requirements Place Heavy Administrative Burden on Physicians Seeking to Prescribe New Cholesterol-Lowering Drugs

A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke. So-called proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are self-injected medications approved for individuals with a genetic condition called familial hypercholesterolemia (FH) and those with atherosclerotic cardiovascular disease (ASCVD) who have high cholesterol despite receiving traditional statin medications and other treatments. Results of the study are published in Circulation: Cardiovascular Quality and Outcomes.

Medicine

Channels:

Biomedical Engineering, iPSC, Heart Attack, Infarct, Tissue Transplantation, Cardiomyocytes

Heart-Muscle Patches Made with Human Cells Improve Heart Attack Recovery

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.

Medicine

Channels:

‘Decorated’ Stem Cells Could Offer Targeted Heart Repair

2_1.jpg

“Decorating” cardiac stem cells with platelet nanovesicles can increase the stem cells’ ability to find and remain at the site of heart attack injury and enhance their effectiveness in treatment.

Medicine

Life

Education

Channels:

Kirschstein National Research Service Award, National Institutes of Health, Virginia Tech Carilion Research Institute, NIH, Neuroscience

Graduate Students Land Elusive National Institute of Health Fellowships

350 award__vtcri.jpg

One of the NIH’s training awards, the highly selective Kirschstein fellowship is conferred to top U.S. graduate students in health science-related fields.







Chat now!